Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;136(1):29-34.
doi: 10.1085/jgp.201010436.

Mechanisms of muscle weakness in muscular dystrophy

Affiliations

Mechanisms of muscle weakness in muscular dystrophy

Jeffery A Goldstein et al. J Gen Physiol. 2010 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Effect of dystrophin loss of myofiber function and organization. (A) Normal myofiber and (B) dystrophin-deficient mdx myofiber. Dystrophin and associated proteins are normally found at the rib-like costameres linking sarcomeric Z bands with the plasma membrane. Loss of dystrophin results in disorganized costameres and enhanced membrane leak. Increased edema and inappropriate cytosolic Ca2+ and ROS generation (filled circles and diamonds) contribute further to muscle dysfunction. Increased extracellular matrix deposition surrounding myofibers also occurs and perturbs membrane integrity. This interaction is particularly important during muscle contraction.

Similar articles

Cited by

References

    1. Amann K.J., Renley B.A., Ervasti J.M. 1998. A cluster of basic repeats in the dystrophin rod domain binds F-actin through an electrostatic interaction. J. Biol. Chem. 273:28419–28423 10.1074/jbc.273.43.28419 - DOI - PubMed
    1. Bellinger A.M., Reiken S., Carlson C., Mongillo M., Liu X., Rothman L., Matecki S., Lacampagne A., Marks A.R. 2009. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat. Med. 15:325–330 10.1038/nm.1916 - DOI - PMC - PubMed
    1. Bernasconi P., Torchiana E., Confalonieri P., Brugnoni R., Barresi R., Mora M., Cornelio F., Morandi L., Mantegazza R. 1995. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J. Clin. Invest. 96:1137–1144 10.1172/JCI118101 - DOI - PMC - PubMed
    1. Cohn R.D., van Erp C., Habashi J.P., Soleimani A.A., Klein E.C., Lisi M.T., Gamradt M., ap Rhys C.M., Holm T.M., Loeys B.L., et al. 2007. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 13:204–210 10.1038/nm1536 - DOI - PMC - PubMed
    1. Consolino C.M., Duclos F., Lee J., Williamson R.A., Campbell K.P., Brooks S.V. 2005. Muscles of mice deficient in alpha-sarcoglycan maintain large masses and near control force values throughout the life span. Physiol. Genomics. 22:244–256 10.1152/physiolgenomics.00311.2004 - DOI - PubMed

Publication types

MeSH terms